
Biotech Firms Navigate Challenges: Rampart Bioscience Closes and InflaRx Streamlines Operations
Austin, TX, January 13, 2026 The biopharmaceutical sector faces significant shifts as Rampart Bioscience shuts down operations less than two years after its inception, while InflaRx








